Skip to main content
Cellular & Ageing Research99% purity · HPLCAvailable to orderResearch use only

Glutathione (reduced)

Endogenous tripeptide antioxidant

Also known as GSH, L-γ-glutamyl-L-cysteinylglycine

The most abundant intracellular non-protein thiol, central to redox buffering, detoxification and protein thiol regulation. A standard reagent in oxidative-stress research.

Glutathione (reduced) research peptide vial, Positive Peptides, 99% purity
Glutathione (reduced) research peptide vial, Positive Peptides, 99% purity

Technical information

Values are shown with their status. “Verified” means the value has been checked against a primary database such as PubChem.

Classification
Endogenous tripeptide antioxidant
CAS number
70-18-8 Pending
Molecular formula
C10H17N3O6S Pending
Molecular weight
307.3 g/mol Pending
Sequence / structure
γ-Glu-Cys-Gly Pending

Some values are still being checked and should be treated as provisional until marked verified.

How this compound is tested

HPLC-UV purity and LC-MS identity; the proportion of oxidised dimer (GSSG) is a key quality attribute and should appear on the COA.

Research background

Glutathione is synthesised in all mammalian cells from glutamate, cysteine and glycine. Its reduced (GSH) and oxidised (GSSG) forms constitute the principal cellular redox buffer. It is used in research as a reagent, as a reference compound in antioxidant assays, and as a subject of study in ageing and disease models (Forman et al., 2009).

Mechanisms investigated in published research

These are the mechanisms examined in the cited literature. Describing them is not a claim that the compound produces any effect in humans.

  • Redox buffering via the GSH/GSSG couple and glutathione peroxidase/reductase cycling.
  • Conjugation of electrophiles via glutathione S-transferases.
  • Protein S-glutathionylation as a signalling modification.
Summary of evidence

Laboratory and animal findings are kept separate from human clinical evidence.

Preclinical findings

Large literature across cell and animal models of oxidative stress, hepatotoxicity and ageing.

Human clinical evidence

N-acetylcysteine (a precursor) is a licensed medicine for specific indications; glutathione itself has limited oral bioavailability and human trials of supplementation report inconsistent effects on systemic markers. Licensed uses of related products do not apply to research-grade glutathione.

Limitations and open questions
  • Readily oxidised in solution; GSH:GSSG ratio should be documented for research use.
  • Oral bioavailability in humans is low and variable.

Scientific references

Publications cited on this page. Links open the publisher or PubMed record.

  1. [1]Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine (2009).

    Review Citation pending

Research use only

Glutathione (reduced) is described here for laboratory research. It is not approved for human or veterinary use unless a regulator has said otherwise, and nothing on this page is medical advice or guidance on administration. A disclaimer does not by itself make any activity lawful. Full disclaimer.

Contact options

Talk to the Positive Peptides team about Glutathione (reduced)

Order enquiries, documentation requests and technical questions about this compound — we answer directly, usually within two working days.

For laboratory research only. All compounds described on this website are supplied strictly for in-vitro laboratory research. They are not for human or veterinary use, and no medical or therapeutic claims are made. Researchers remain responsible for complying with the rules that apply to them.

Full disclaimer